Insider buying last 90 days
No open-market insider purchases were filed for BDX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every BDX insider filing, plotted on the chart in Gekko.Open BDX in Gekko
NYSE: BDX
Becton, Dickinson (BDX) Stock Analysis & Forecast
Nov 4 close
$209.19+11.02 (+5.6%)
Gekko Brief
Nov 4 closeBecton, Dickinson closed at $209.19 on 4 November 2026, +5.6% on the day. The price sits above both the 50-day ($187.27) and 200-day ($166.57) moving averages, inside a 52-week range of $100.31 to $209.84. The GekkoIndex reads 41.2, in the Distribution zone, down 8.5 points over five sessions. Gekko Fair Value is $330.03, so the price is 36.6% below it.
The next earnings report is due on 5 November 2026, today (before open). Over the last 8 reports the company beat the earnings estimate 8 times, with an average move of 6.5% across the report. Smart-money activity over the last 90 days includes 1 Congress purchase and 0 sales. Seasonally, the next 20 trading days from this point averaged +7% over the last 5 years, rising in 3 of them.
10 firms rate the stock: 4 buy, 5 hold and 1 sell, with a consensus target of $195.57. A typical daily move is about 2%, and a typical 20-day move about 3.5%. On the swing-trade checklist, 4 items read supportive and 2 read as a headwind (gekkoindex, earnings risk).
A plain summary of the figures as of the Nov 4, 2026 close.
Becton, Dickinson price vs fair value
Close $209.19200-day averageGekko Fair Value $330.03
Becton, Dickinson quick facts
- Market cap
- $56.98B
- P/E ratio
- 46
- Forward P/E
- 14.9
- EPS, TTM
- $4.32
- Revenue, TTM
- $22.48B
- Profit margin
- 4.2%
- Dividend yield
- 2.12%
- Beta
- 0.28
- Volume
- 4.46M avg 1.70M
- 1-year return
- +90.9%
- Typical daily move
- ±2%
- Typical 20-day move
- ±3.5%
- 50-day average
- $187.27
- 200-day average
- $166.57
- Next earnings
- Nov 5 before open
- Shares outstanding
- 272.4M
Becton, Dickinson swing-trade checklist
Becton, Dickinson scores 4 supportive, 0 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive0 mixed2 headwinds
- Trendsupportive
Above 50 and 200-day
Close $209.19 is above the 50-day ($187.27) and 200-day ($166.57) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexheadwind
41.2, Distribution
Reading 41.2 is in the Distribution zone.
See the GekkoIndex - Fair valuesupportive
36.6% below
Price is 36.6% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: Congress 1 buy / 0 sales.
See smart money - Earnings riskheadwind
Reports today
Reports on Nov 5, 2026, today — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+7.0% on average
From this point in the calendar, the next 20 trading days averaged +7% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Becton, Dickinson stock chart and price history
Becton, Dickinson closed at $209.19 on Nov 4, 2026, +90.9% over the past year, inside a 52-week range of $100.31 to $209.84.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +16.0%
- 3 months
- +18.1%
- 6 months
- +44.5%
- 1 year
- +90.9%
The full BDX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open BDX in Gekko
Follow Becton, Dickinson through every session
Put BDX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track BDX in GekkoFree for 7 days. No credit card required.
About Becton, Dickinson
Becton, Dickinson makes and sells medical technology worldwide, ranging from everyday medical supplies to advanced diagnostic and laboratory equipment. It is known for producing a wide array of devices used across hospitals, labs, and treatment settings, spanning drug delivery, diagnostics, and surgical care. Its customers include hospitals, clinics, research organizations, pharmaceutical companies, and members of the public who rely on its products indirectly through healthcare providers.
The company organizes its work into three areas. One focuses on medication delivery and IV access, covering catheters, syringes, needles, infusion systems, and diabetes care tools such as pen needles. Another centers on diagnostics and research, supplying blood and specimen collection products, automated testing systems for infections like tuberculosis, cytology tools, and cell analysis equipment used in oncology and immunology work. The third addresses surgical and interventional needs, including products for hernia repair, tissue grafts, and other biosurgery applications.
Shares of Becton, Dickinson trade on the NYSE under the ticker BDX.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- bd.com
Becton, Dickinson GekkoIndex: the smart money zone
Becton, Dickinson’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 41.2, in the Distribution zone, down 8.5 points over five sessions.
41.2Distribution
Down 8.5 points over five sessions, from the Neutral zone.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 23 | +0.9% | −0.2% | ||
| Accumulation | 243 | +0.3% | +0.7% | ||
| Neutral | 398 | +0.2% | +1.7% | ||
| Distribution (current zone) | 32 | +1.0% | −2.1% | ||
| Selling | 1 | Too few readings yet | |||
Average BDX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Distribution readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Distribution zone: Institutions potentially offloading. About the five zones →
See every daily GekkoIndex reading plotted over the BDX price, zone by zone.Track BDX in Gekko
Is Becton, Dickinson stock overvalued? Gekko Fair Value
Becton, Dickinson trades 36.6% below Gekko Fair Value of $330.03, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Becton, Dickinson shares are worth, recalculated every trading day.
$330.03
Gekko Fair Value, Nov 4, 2026
36.6% Undervalued
At the end of Aug 2026 the price was 1.8% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open BDX in Gekko
Becton, Dickinson insider and Congress trading
No open-market insider purchases were filed for Becton, Dickinson, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 11 |
From congressional disclosures, which report amounts as ranges.
Buybacks
Becton, Dickinson has been buying back its own shares.
- Latest authorization
- $2.00B, Feb 9, 2026
- Bought back, quarter ended Jun 30, 2026
- $2.25B
- As a share of market cap
- 3.95%
- Trailing four quarters
- $3.00B
From company filings.
Hedge funds and billionaires quarter ended Sep 30
0of the funds Gekko tracks hold BDX.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Becton, Dickinson earnings: next date and track record
Becton, Dickinson reports on Nov 5, 2026, before the open (today), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected before the open, today
- EPS estimate
- $4.07
- Revenue estimate
- $5.11B
8 of 8reports beat the EPS estimate
±6.5%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 6, 2026 AI summary
- What they said
- BDX delivered Q3 fiscal 2026 revenue of $5 billion, up 4.4% FX-neutral, with adjusted operating margin of 24.9% and adjusted EPS of $3.23, all exceeding expectations. This was the first full quarter as 'New BD' post Life Sciences spin-off. Growth drivers included double-digit gains in biologic drug delivery, advanced patient monitoring, PureWick, and advanced tissue regeneration. ~100 GLP-1 agreements signed; Alaris gained 200+ bps share year-to-date.
- Guidance
- BDX raised full-year guidance, now expecting revenue growth toward the high end of the low single-digit range and raised the midpoint of adjusted EPS guidance, reflecting strong year-to-date execution and continued momentum across key growth platforms.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $3.23 est $3.14 | $4.98B est $4.89B | +3.6% |
| May 7, 2026 | $2.90 est $2.77 | $4.71B est $4.67B | +3.2% |
| Feb 9, 2026 | $2.91 est $2.80 | $4.49B est $5.15B | +4.0% |
| Nov 6, 2025 | $3.96 est $3.92 | $5.89B est $5.91B | +0.8% |
| Aug 7, 2025 | $3.68 est $3.40 | $5.51B est $5.49B | +12.2% |
| May 1, 2025 | $3.35 est $3.28 | $5.27B est $5.35B | −18.5% |
| Feb 5, 2025 | $3.43 est $2.99 | $5.17B est $5.10B | −6.3% |
| Nov 7, 2024 | $3.81 est $3.77 | $5.44B est $5.38B | −3.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Becton, Dickinson stock forecast and analyst price targets
Analysts’ average 12-month price target for Becton, Dickinson is $195.57, −6.5% from the last close, from 10 firms rating the stock in the last 90 days.
$195.57consensus 12-month target, −6.5% from the last close
Now $209.19Avg $195.57
Low $165High $210
Each firm’s latest rating in the last 90 days: 10 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 7 | Barclays | $165 | −21.1% |
| Oct 6 | Bank of America Securities | $200 | −4.4% |
| Oct 5 | Citi | $208 | −0.6% |
| Oct 1 | RBC Capital | $190 | −9.2% |
| Sep 8 | Jefferies | $210 | +0.4% |
−2.1%average 20-day move after past Distribution readings
+7.0%average move over the next 20 trading days in the last 5 years
±2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Becton, Dickinson seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Becton, Dickinson averaged +7.0% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | 0.0% | 4 of 5 |
| Next 10 trading days | +5.3% | 3 of 5 |
| Next 15 trading days | +7.1% | 3 of 5 |
| Next 20 trading days | +7.0% | 3 of 5 |
| Next 30 trading days | +8.9% | 3 of 5 |
For scale, BDX’s typical 20-trading-day move in either direction is about 3.5%.
Becton, Dickinson market cap and key statistics
Becton, Dickinson’s market cap is $56.98B, with a P/E ratio of 46 and revenue of $22.48B over the last twelve months.
Valuation
- Market cap
- $56.98B
- P/E ratio
- 46
- Forward P/E
- 14.9
- EPS, TTM
- $4.32
- Gekko Fair Value
- $330.03
Trading
- Volume
- 4.46M
- Avg volume, 20 days
- 1.70M
- 52-week high
- $209.84
- 52-week low
- $100.31
- Shares outstanding
- 272.4M
Financials
- Revenue, TTM
- $22.48B
- Profit margin
- 4.2%
- Return on equity
- 6.6%
- Quarterly earnings growth, YoY
- −31.4%
Risk and income
- Beta
- 0.28
- Typical daily move
- ±2%
- Typical 20-day move
- ±3.5%
- Dividend yield
- 2.12%
Becton, Dickinson stock news this week
Coverage of Becton, Dickinson this week reads positive: 3 positive, 3 neutral and 0 negative headlines.
- Becton, Dickinson and Company (BDX) Names Bridget Bagnato Peripheral Intervention PresidentTradingView, Nov 4
- BECTON, DICKINSON AND COMPANY (4BDX.TI) stock major holdersYahoo Finance UK, Nov 3
- BDX Gears Up to Report Q4 Results: How to Play the Stock?TradingView, Nov 3
- Becton Dickinson (BDX) Q4 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research, Nov 3
- Becton, Dickinson and Company (BDX) Seasonal returns chartYahoo Finance UK, Oct 29
- Becton, Dickinson and Company (BDX) Seasonal Returns Chart - Yahoo FinanceYahoo! Finance Canada, Oct 29
Becton, Dickinson peers
Becton, Dickinson’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 14.5% above |
| ABTAbbott Laboratories | Distribution | 8.0% below |
| ISRGIntuitive Surgical | Distribution | 30.4% above |
| DHRDanaher | Neutral | 3.6% above |
| MDTMedtronic | Neutral | 16.0% below |
| SYKStryker | Distribution | 6.5% above |
A peer links to its own page where one exists.
Becton, Dickinson stock FAQ
What is Becton, Dickinson’s market cap?
Becton, Dickinson’s market cap is $56.98B at the Nov 4, 2026 close of $209.19, with 272.4M shares outstanding. The shares trade on a P/E ratio of 46.
What is the Becton, Dickinson stock forecast?
The consensus analyst 12-month price target for Becton, Dickinson is $195.57, −6.5% from the last close. Of the 10 firms that rated the stock in the last 90 days, 4 rate it a buy, 5 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is Becton, Dickinson stock overvalued or undervalued?
On Gekko’s estimate Becton, Dickinson is undervalued: the Nov 4, 2026 close of $209.19 is 36.6% below Gekko Fair Value of $330.03. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Becton, Dickinson report earnings next?
Becton, Dickinson is expected to report on Nov 5, 2026, before the market opens (today). Analysts expect earnings of $4.07 per share on revenue of $5.11B. Becton, Dickinson beat the earnings estimate in 8 of its last 8 reports, moving 6.5% on average across the report.
What is Becton, Dickinson’s 52-week high and low?
Becton, Dickinson’s 52-week high is $209.84 and its 52-week low is $100.31; it closed at $209.19 on Nov 4, 2026, +90.9% over the past year. Over the last five years the shares peaked at $225.88 on Jul 24, 2023.
Is Becton, Dickinson stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (trend, fair value, smart money and seasonality) and 2 as headwinds (gekkoindex and earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Becton, Dickinson the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.